Antioxidants in health and disease

Journal of Clinical Pathology

Volumn 54, Issue 3, 2001, Pages 176-186

  Young, I S ^a   Woodside, J V ^b  

^a Institute of Clinical Sciences B   (United Kingdom)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Antioxidants; Atherosclerosis; Coronary heart disease; Free radicals; Oxidative stress

Indexed keywords

ANTIOXIDANT; CATALASE; FREE RADICAL; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; SUPEROXIDE DISMUTASE;

ATHEROSCLEROSIS; CELL FUNCTION; DECOMPOSITION; HUMAN; ISCHEMIC HEART DISEASE; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SCAVENGING SYSTEM; TISSUE INJURY;

ANTIOXIDANTS; CORONARY DISEASE; FREE RADICALS; HUMANS; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 0035095323     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.3.176     Document Type: Review

References (143)

1. The definition and measurement of antioxidants in biological systems
2. Biologically relevant metal ion-dependent hydroxyl radical generation - An update
3. Generation of superoxide in cardiomyocytes during ischemia before reperfusion
4. Superoxide release by confluent endothelial cells, an electron spin resonance (ESR) study
5. Protein kinase C-epsilon mediates glucose-induced superoxide production and MCP-1 expression in endothelial cells
6. Cellular signalling: The role of the peroxisome
7. Chronic granulomatous disease
8. Hydroperoxide metabolism in mammalian organs
9. Role of free radicals and catalytic metal ions in human disease: An overview
10. Singlet oxygen as the principal oxidant in myeloperoxidase-mediated bacterial killing in neutrophil phagosomes
11. The origin of the hydroxyl radical oxygen in the Fenton reaction
12. Oxidative mechanisms in the toxicity of metal ions
13. Regulation of mammalian iron metabolism: Current state and need for further knowledge
14. Superoxide-dependent and ascorbate-dependent formation of hydroxyl radicals from hydrogen peroxide in the presence of iron
15. Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts
16. Transient iron overload with bleomycin detectable iron in the plasma of patients with adult respiratory distress syndrome
17. Sequential oxidative damage, and changes in iron binding and iron oxidizing plasma antioxidants during cardiopulmonary bypass surgery
18. Malondialdehyde formation from lipid hydroperoxides in the thiobarbituric acid test: The role of lipid radicals, iron salts and metal chelators
19. Formation of hydroxyl radicals in the presence of ferritin and haemosiderin. Is haemosiderin formation a biological protective mechanism?
20. The production of activated oxygen species by an interaction of methemoglobin with ascorbate
21. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activities in human atherosclerotic material
22. A marked increase in free copper levels in the plasma and liver of LEC rats: An animal model for Wilson disease and liver cancer
23. Photodynamic therapy - A review
24. Oxidants, antioxidants, and respiratory tract lining fluids
25. The free radical basis of air pollution focus on ozone
26. Nitrogen dioxide depletes uric acid and ascorbic acid but not glutathione from lung lining fluid
27. Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5- (hydroxymethyl) uracil in smokers
28. Hydrogen peroxide in the breath of rats: The effects of hypoxia and paraquat
29. Paracetamol catalyzes myeloperoxidase-initiated lipid oxidation in LDL
30. Free radicals and antioxidants in chemotherapy-induced toxicity
31. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracydine antibiotics adriamycin and daunorubicin
32. The function of catalase-bound NADPH
33. Selenium-dependent glutathione peroxidase protein and activity: Immunological investigations on cellular and plasma enzymes
34. Effect of selenium deficiency on cellular and extracellular glutathione peroxidases: Immunochemical detection and mRNA analysis in rat kidney and serum
35. Tissue-specific Functions of individual glutathione peroxidases
36. Plasma glutathione peroxidase activity is reduced in haemodialysis patients
37. The diverse role of selenium within selenoproteins: A review
38. GSH-dependent inhibition of lipid peroxidation: Properties of a potent cytosolic system which protects cell membranes
39. Distribution of CuZn superoxide dismutase in rat liver
40. Mitochondrial superoxide dismutase: Site of synthesis and intramitochondrial location
41. Human copper-containing superoxide dismutase of high molecular weight
42. Pharmacokinetics of extracellular superoxide dismutase in the vascular system
43. Endothelial function hypertension - The role of superoxide anion
44. Biomarkers of free radical damage applications in experimental animals and in humans
45. How to characterize an antioxidant: An update
46. Role of vitamin E in preventing the oxidation of low-density lipoprotein
47. Data supporting supplementation of humans with vitamin E
48. Vitamin-E - Inhibition of retinol-induced hemolysis and membrane-stabilizing behavior
49. Anaemia, vitamin E deficiency and failure to thrive in an infant
50. Vitamin E deficiency and neurologic disease
51. Absorption, lipoprotein transport, and regulation of plasma concentrations of vitamin E in humans
52. Vitamin E: Applications of the principles of physical organic chemistry to the exploration of its structure and function
53. Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid
54. Recycling and redox cycling of phenolic antioxidants. Towards prolongation of the healthy life span
55. Dietary carotenoids and certain cancers, heart disease, and age-related macular degeneration: A review of recent research
56. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes
57. Intracellular antioxidants: From chemical to biochemical mechanisms
58. Antioxidant activity of retinol, glutathione, and taurine in bovine photoreceptor cell membranes
59. Structure-antioxidant activity relationships of flavonoids and phenolic acids
60. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands
61. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices
62. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen elderly study
63. Flavonoid intake and long-term risk of coronary-heart-disease and cancer in the 7 countries study
64. Relation between intake of flavonoids and risk of coronary heart disease in male health professionals
65. Absorption of dietary quercetin glycosides and quecetin in healthy ileostomy volunteers
66. Absorption and antioxidant effects of quercetin from onions in man
67. In vivo antioxidant effect of green and black tea in man
68. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease
69. Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation
70. Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol, against lipid peroxidation
71. Electron transport-linked ubiquinone-dependent recycling of alpha-tocopherol inhibits autooxidation of mitochondrial membranes
72. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation
73. Criteria and recommendations for vitamin C intake
74. New concepts in the biology and biochemistry of ascorbic acid
75. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein
76. Ascorbyl free-radical - A noninvasive marker of oxidative stress in human open heart surgery
77. Reduction of the ascorbyl free radical to ascorbate by thioredoxin reductase
78. Ascorbate recycling in human erythrocytes: Role of GSH in reducing dehydroascorbate
79. Evaluation of an acidic deproteinization for the measurement of ascorbate and dehydroascorbate in plasma samples
80. Measurement of allantoin and uric acid in human body fluids. A potential index of free-radical reactions in vivo?
81. Oxidative damage to human plasma proteins by ozone
82. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer
83. Antioxidant defences and lipid peroxidation in human blood plasma
84. Bilirubin and ascorbate antioxidant activity in neonatal plasma
85. Albumin - An important extracellular antioxidant?
86. Endogenous antioxidant defences in human blood plasma
87. Antioxidant protection against hypochlorous acid in human plasma
88. Differing features of proteins in membranes may result in antioxidant or prooxidant action: Opposite effects on lipid peroxidation of alcohol dehydrogenase and albumin in liposomal systems
89. Glutathione, oxidative stress and aging
90. Gene expression and the thiol redox state
91. Anti- and pro-oxidant effects of ascorbate on iron-mediated oxidative damage to bovine serum albumin
92. Requirement for, promotion, or inhibition by alpha-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation
93. Direct evidence of caeruloplasmin antioxidant properties
94. The isoprostanes: Novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid
95. Inflammation, lipids, and free radicals: Lessons learned from the atherogenic process
96. Tobacco smoke carcinogens and lung cancer
97. The aging paradox: Free radical theory of aging
98. Role of oxidized LDL in atherogenesis
99. The role of oxidized LDL in atherogenesis: Immunological response and antiphospholipid antibodies
100. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
101. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
102. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by the receptor for acetylated low density lipoproteins
103. Lipoxygenase contributes to the oxidation of lipids in human atherosclerotic plaques
104. Sensitive detection of oxidatively modified low-density lipoprotein using a monoclonal antibody
105. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
106. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man
107. What is the significance of ceroid in human atherosclerosis?
108. Monocyte transmigration induced by modifications of LDL in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by HDL
109. LDL cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cell culture
110. Impairment of endothelial-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins
111. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
112. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL
113. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
114. Oxidized LDL and expression of monocyte adhesion molecules
115. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism
116. Interactions of oxidants with vascular signaling systems
117. The antioxidant butylated hydroxytoluene protects against atherosclerosis
118. Effects of d-alpha-tocopherol supplementation on experimentally induced primate atherosclerosis
119. Ubiquinol-10 protects human low-density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol
120. Effect of antioxidants on oxidative modification of LDL
121. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene
122. Inverse correlation between vitamin E and mortality from ischaemic heart disease in cross-cultural epidemiology
123. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene
124. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in eastern Finnish men
125. Vitamin E consumption and the risk of coronary heart disease in men
126. Vitamin E consumption and the risk of coronary heart disease in women
127. Vitamin C intake and mortality among a sample of the United States population
128. Vitamin C deficiency and risk of myocardial infarction: Prospective population study of men from eastern Finland
129. The role of beta-carotene in the prevention of cardiovascular disease
130. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers
131. Randomised trial of u-tocopherol and β-carotene supplements on incidence of major coronary events in men with previous myocardial infarction
132. Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population
133. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
134. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease
135. Mortality associated with low plasma concentration of beta-carotene and the effect of oral supplementation
136. Serial coronary angiographic evidence that antioxidant vitamin intake reduced progression of coronary artery atherosclerosis
137. Usefulness of antioxidant vitamins in suspected acute myocardial infarction
138. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge heart antioxidant study (CHAOS)
139. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
140. Vitamin E supplementation and cardiovascular events in high-risk patients
141. Dietary antioxidants and plasma lipids: The CARDIA study
142. Passive smoking induces atherogenic changes in low-density lipoprotein